How well will Biogen's Alzheimer's drug Aduhelm perform in the real world? This...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 29, 2021 at 11:12 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,989
    Likes Received:
    3
    via While all eyes are on Biogen’s FDA-required Aduhelm trial that will determine whether the treatment actually aids Alzheimer’s disease patients, the company is involved in another real-world study in the works assessing its worth in an array of people coping with the memory-robbing disease.

    article source